Fact-sheet: Peritoneal mesothelioma


Updated on 04/19/2018 at 11:39 AM

Rating: 0/10

View all RADEOS cases associated with this fact-sheet

Definition

Peritoneal mesothelioma (PM) = Primary malignant peritoneal tumor arising from the parietal cells (mesothelium) of the peritoneal cavity

  • Arises from the coelomic cavities (pleural > peritoneal > pericardial > vaginal localization)
  • May be benign or malignant
  • Risk factor: Asbestos +++

Clinical features

  • General health deterioration
  • Ascites
  • Abdominal pain
  • Bowel transit disorders
  • Palpable abdominal mass

CT

Highly variable

  • Ascites: 80%

  • Greater omentum: 75%

  • Nodules of the extra-omental peritoneal fat: 40%

  • Densification of the extra-omental peritoneal fat: 40%

  • Thickening of the peritoneal fascia: 25%

  • Pleural involvement: 25%

  • Mesentery: 20%

  • Adjacent cysts: 10%

Summary

  • Ascites very common but absent in sarcomatoid PM

  • Encasement of organs but never scalloping

  • Nodules of the peritoneal fat and thickening of the peritoneal fascia: exclusively malignant PM

  • Non-nodular fat densification: most often malignant PM (occasionally benign)

Management

 

  • Malignant PM

    • Cytoreductive surgery + HIPEC

      • 5-year survival: 50%

      • Median 60 months

    • Chemotherapy.

  • Benign PM

    • Surgical treatment (no indication for chemotherapy)

    • Excellent prognosis -> e.g., multicystic PM: 90% 5-year survival.

Classification

 

  • Malignant PM

    • epithelioid

    • biphasic

    • sarcomatoid

  • Benign PM

    • well-differentiated papillary

    • multicystic

    • adenomatoid

    • peritoneal inclusion cyst

Differential diagnosis

  • Neoplastic
    Peritoneal carcinomatosis (primary lesion, visceral metastases)
  • Peritoneal pseudomyxoma (scalloping)
  • Desmoplastic small round cell tumor (young male, large tissue masses +/- calcified, metastases)
  • Primary peritoneal papillary serous carcinoma
  • Peritoneal lymphoma (coalescent nodal masses with homogeneous enhancement)
  • Infectious Peritoneal tuberculosis (loculated ascites, numerous lymphadenopathies)